Stomach Cancer Trial, Recruiting NCT07635316 Sponsor: Novartis Pharmaceuticals Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07635316
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a type of cancer called a gastroenteropancreatic neuroendocrine tumour (GEP-NET), recorded in medical records at some point between 1 January 2018 and 31 December 2025.
  • People who started a first course of treatment for GEP-NET — such as certain hormone-like drugs, targeted medicines, a type of radiation therapy, or chemotherapy — on or after the date their diagnosis was first recorded.
  • People who were 18 years of age or older when they started that first treatment.
  • People whose health insurance or medical records show continuous coverage for at least 12 months before their treatment start date, with medical or pharmacy claims spread across that period (confirm with trial site).
  • People whose health records show at least one month of data after their treatment start date, including records from the pharmacy or prescribing doctor who provided the GEP-NET treatment (confirm with trial site).

Who may not be able to join:

  • People whose records show signs of GEP-NET before the date their diagnosis was first officially recorded within the study period.
  • People whose records show they received GEP-NET treatment before the date their first treatment was officially recorded within the study period.
  • People whose age or sex is missing or recorded incorrectly in their medical records.
  • People who had another separate primary cancer diagnosed in the 12 months before their GEP-NET treatment start date.
  • People whose records contain an invalid death date — for example, where the recorded date of death is listed as the same day as or earlier than their treatment start date.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Novartis Pharmaceuticals, Novartis Pharmaceuticals

Phone: +41613241111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 June 2026
Est. completion
25 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of Lines of Therapy (LOTs); Number and Percentage of Patients by Treatment Regimen per LOT; Number and Percentage of Patients by Type of Therapy in Each LOT; Number and Percentage of Patients who Discontinue all Medications Within the 1L Treatment Regimen; Number of Cycles of Medications Within the Treatment Regimen Before Discontinuation; Time to 1L Treatment Discontinuation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov